Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology 21 January 2026 Investment in Canadian headquarters fuels expansion of Canadian operations, advancing access to innovative cancer medicines. 4 minute read Read More 0 0 0 0 0 0 0 0
